Skip to main content
OpenTrials
Completed

NCT Number: NCT02681354

Dual Task Training in Elderly Using the BioRescue

Mild cognitive impairment (MCI) is accompanied by gait and balance problems while dual tasking. During a 6 to 8 weeks training with the BioRescue (virtual reality), institutionalized elderly people with MCI will relearn dual tasks in combination with balance. Afterwards, the transferring effect on gait in general, balance and cognition will be examined.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Mild Cognitive Impairment Cognition Disorders Cognitive Dysfunction Mental Disorders Neurocognitive Disorders

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hasselt University, Diepenbeek, Belgium

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • minimum age: 65
  • Participants with increased fall-risk (i.e. Timed Up-and-Go Test (TUG) > 20 sec)
  • Participants with Mild Cognitive Impairment (MCI) measured by the Montreal Cognitive Assessment (MoCa < 25). MCI: A state of altered cognition, characterized by a decline in one or more cognitive domains, typically including memory while the independence for daily activities remains intact.
  • Participants have a positive result on the 'Stops Walking While Talking' test

Exclusion criteria

  • Diagnosis of Dementia, based on a specialized diagnostic bilan of a doctor-specialist.
  • In rehabilitation for a recent injury or recent prothesis of the upper or lower extremities.
  • Serious limitations of the lower and or upper limb.
  • Not able to walk more than 10 meters independently (walking-aid allowed).

Treatment and study plan

Biorescue training

Other

Primary outcomes

  1. Static balance

    Time frame: day 1

    measured using the BioRescue

  2. Static balance

    Time frame: week 8

    measured using the BioRescue

  3. Dynamic Balance

    Time frame: day 1

    instrumented timed Up-and-Go test

  4. Dynamic Balance

    Time frame: week 8

    instrumented timed Up-and-Go test

  5. instrumented timed Up-and-Go test while dual-tasking

    Time frame: day 1

    instrumented timed Up-and-Go test while dual-tasking

  6. instrumented timed Up-and-Go test while dual-tasking

    Time frame: week 8

    instrumented timed Up-and-Go test while dual-tasking

  7. "stops walking while talking" test

    Time frame: day 1

    "stops walking while talking" test

  8. "stops walking while talking" test

    Time frame: week 8

    "stops walking while talking" test

Secondary outcomes

  1. fall incidence

    Time frame: up to 8 weeks

    The incidence of falls for each participant will be registered in the institution

  2. cognitive function

    Time frame: day 1

    measured by the MOCA (Montreal Cognitive Assesment)

  3. cognitive function

    Time frame: week 8

    measured by the MOCA (Montreal Cognitive Assesment)

Sponsors and collaborators

Lead sponsor

Hasselt University

Other

Registry information

Official study title

What is the Influence of Dualtask-training With the BioRescue (Analyses and Rehabilitation of Mobility) on Static Balance, Dynamic Balance During Gait and Cognitive-motor Dual Tasks During Gait: A Randomized Controlled Trial

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Feb 12, 2016
Registry last updated
Jun 14, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.